Literature DB >> 19896460

CID755673 enhances mitogenic signaling by phorbol esters, bombesin and EGF through a protein kinase D-independent pathway.

Eugenia Torres-Marquez1, James Sinnett-Smith, Sushovan Guha, Robert Kui, Richard T Waldron, Osvaldo Rey, Enrique Rozengurt.   

Abstract

Recently, CID755673 was reported to act as a highly selective inhibitor of protein kinase D (PKD). In the course of experiments using CID755673, we noticed that it exerted unexpected stimulatory effects on [(3)H]thymidine incorporation and cell cycle progression in Swiss 3T3 cells stimulated by bombesin, a Gq-coupled receptor agonist, phorbol 12,13-dibutyrate (PDBu), a biologically active tumor promoting phorbol ester and epidermal growth factor (EGF). These stimulatory effects could be dissociated from the inhibitory effect of CID755673 on PKD activity, since enhancement of DNA synthesis was still evident in cells with severely down-regulated PKD1 after transfection of siRNA targeting PKD1. A major point raised by our study is that CID755673 can not be considered a specific inhibitor of PKD and it should be used with great caution in experiments attempting to elucidate the role of PKD family members in cellular regulation, particularly cell cycle progression from G(1)/G(o) to S phase. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896460      PMCID: PMC2812606          DOI: 10.1016/j.bbrc.2009.11.002

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

1.  Activation of protein kinase D by signaling through Rho and the alpha subunit of the heterotrimeric G protein G13.

Authors:  J Yuan; L W Slice; E Rozengurt
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

2.  Protein kinase C phosphorylates protein kinase D activation loop Ser744 and Ser748 and releases autoinhibition by the pleckstrin homology domain.

Authors:  Richard T Waldron; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2002-10-28       Impact factor: 5.157

3.  Cooperation of Gq, Gi, and G12/13 in protein kinase D activation and phosphorylation induced by lysophosphatidic acid.

Authors:  Jingzhen Yuan; Lee W Slice; Jennifer Gu; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2002-12-10       Impact factor: 5.157

4.  Spatial and temporal regulation of protein kinase D (PKD).

Authors:  S A Matthews; T Iglesias; E Rozengurt; D Cantrell
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

5.  Activation loop Ser744 and Ser748 in protein kinase D are transphosphorylated in vivo.

Authors:  R T Waldron; O Rey; T Iglesias; T Tugal; D Cantrell; E Rozengurt
Journal:  J Biol Chem       Date:  2001-06-15       Impact factor: 5.157

6.  Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1.

Authors:  Sushovan Guha; Osvaldo Rey; Enrique Rozengurt
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

7.  Protein kinase D potentiates DNA synthesis and cell proliferation induced by bombesin, vasopressin, or phorbol esters in Swiss 3T3 cells.

Authors:  E Zhukova; J Sinnett-Smith; E Rozengurt
Journal:  J Biol Chem       Date:  2001-08-20       Impact factor: 5.157

8.  Protein kinase D mediates mitogenic signaling by Gq-coupled receptors through protein kinase C-independent regulation of activation loop Ser744 and Ser748 phosphorylation.

Authors:  James Sinnett-Smith; Rodrigo Jacamo; Robert Kui; Yunzu M Wang; Steven H Young; Osvaldo Rey; Richard T Waldron; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

9.  Protein kinase D. A selective target for antigen receptors and a downstream target for protein kinase C in lymphocytes.

Authors:  S A Matthews; E Rozengurt; D Cantrell
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

10.  Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis.

Authors:  Grzegorz Sumara; Ivan Formentini; Stephan Collins; Izabela Sumara; Renata Windak; Bernd Bodenmiller; Reshma Ramracheya; Dorothée Caille; Huiping Jiang; Kenneth A Platt; Paolo Meda; Rudolf Aebersold; Patrik Rorsman; Romeo Ricci
Journal:  Cell       Date:  2009-01-08       Impact factor: 41.582

View more
  11 in total

1.  A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo.

Authors:  Kuzhuvelil B Harikumar; Ajaikumar B Kunnumakkara; Nobuo Ochi; Zhimin Tong; Amit Deorukhkar; Bokyung Sung; Lloyd Kelland; Stephen Jamieson; Rachel Sutherland; Tony Raynham; Mark Charles; Azadeh Bagherzadeh; Azadeh Bagherazadeh; Caroline Foxton; Alexandra Boakes; Muddasar Farooq; Dipen Maru; Parmeswaran Diagaradjane; Yoichi Matsuo; James Sinnett-Smith; Juri Gelovani; Sunil Krishnan; Bharat B Aggarwal; Enrique Rozengurt; Christopher R Ireson; Sushovan Guha
Journal:  Mol Cancer Ther       Date:  2010-05-04       Impact factor: 6.261

Review 2.  Protein kinase D as a potential new target for cancer therapy.

Authors:  Courtney R LaValle; Kara M George; Elizabeth R Sharlow; John S Lazo; Peter Wipf; Q Jane Wang
Journal:  Biochim Biophys Acta       Date:  2010-05-24

Review 3.  Role of protein kinase D signaling in pancreatic cancer.

Authors:  Sushovan Guha; Suebpong Tanasanvimon; James Sinnett-Smith; Enrique Rozengurt
Journal:  Biochem Pharmacol       Date:  2010-07-16       Impact factor: 5.858

4.  The potential use of protein kinase D inhibitors for prevention/treatment of epidermal tumors.

Authors:  Senthil Nathan Arun; Ding Xie; M Ernest Dodd; Xiaofeng Zhong; Wendy B Bollag
Journal:  J Dermatol Sci       Date:  2010-08-10       Impact factor: 4.563

5.  Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease.

Authors:  Muhammet Ay; Jie Luo; Monica Langley; Huajun Jin; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  J Neurochem       Date:  2017-05-09       Impact factor: 5.372

6.  Bradykinin stimulates protein kinase D-mediated colonic myofibroblast migration via cyclooxygenase-2 and heat shock protein 27.

Authors:  Eric Chu; Shyla Saini; Tiegang Liu; James Yoo
Journal:  J Surg Res       Date:  2016-10-20       Impact factor: 2.192

7.  Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility.

Authors:  Courtney R Lavalle; Karla Bravo-Altamirano; Karthik V Giridhar; Jun Chen; Elizabeth Sharlow; John S Lazo; Peter Wipf; Q Jane Wang
Journal:  BMC Chem Biol       Date:  2010-05-05

8.  Characterization of the biological effects of a novel protein kinase D inhibitor in endothelial cells.

Authors:  Ian M Evans; Azadeh Bagherzadeh; Mark Charles; Tony Raynham; Chris Ireson; Alexandra Boakes; Lloyd Kelland; Ian C Zachary
Journal:  Biochem J       Date:  2010-08-01       Impact factor: 3.857

9.  Protein kinase C mediates platelet secretion and thrombus formation through protein kinase D2.

Authors:  Olga Konopatskaya; Sharon A Matthews; Matthew T Harper; Karen Gilio; Judith M E M Cosemans; Christopher M Williams; Maria N Navarro; Deborah A Carter; Johan W M Heemskerk; Michael Leitges; Doreen Cantrell; Alastair W Poole
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

10.  Design, Synthesis, and Biological Evaluation of PKD Inhibitors.

Authors:  Kara M George; Marie-Céline Frantz; Karla Bravo-Altamirano; Courtney R Lavalle; Manuj Tandon; Stephanie Leimgruber; Elizabeth R Sharlow; John S Lazo; Q Jane Wang; Peter Wipf
Journal:  Pharmaceutics       Date:  2011       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.